![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, December 04, 2015 1:24:22 AM
"Woodford said it was too soon to say whether the £120million bet on Northwest Biotherapeutics had gone badly." He's saying maybe, maybe not
"With some early-stage investments not everything will go well. It is too early to pass judgment on Northwest, but we have hit a bump in the road that needs to be addressed."
NW is uncertain if there is a serious problem, but he is concerned enough to demand for an ex FBI investigator's inclusion on the bod. He is actually in the same position as many of us. Invested for the potential of the science and the early clinical results, but has some concerns about the management and some of the "allegations".
And let's not forget about his prior comment regarding the timing of when he became aware of these issues and the implications this may have on future financing until full resolution is accomplished.
Look, I'm not trying to scare anyone or spread fud. I'm not someone without any interest that is "looking out for you". I'm in the same boat. Trying to figure this out. Don't know if I should sell or stay. There are strong points on either side of the argument. But we need to look at this for what it really is.
It seems highly unlikely to me that there is a coordinated effort between NW and LP. I could be wrong, but the evidence just doesn't point me in that direction. No offense Senti, I hope you won't take it personally. The reality is that our biggest backer is concerned. Should we be? I'm still long, but I am very concerned as well. In my mind the risk factor has greatly increased in recent weeks.
My biggest questions are these. What if NW finds something wrong? Will that completely erode his confidence in the current management team? Will he continue to pump more money in? Does he have the power/ownership to force any necessary changes? If not, then what happens? Does he exit? Sorry this got to be so long.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM